InvestorsHub Logo
Followers 18
Posts 6665
Boards Moderated 0
Alias Born 03/06/2010

Re: imanjen13 post# 372504

Friday, 08/19/2022 12:48:40 PM

Friday, August 19, 2022 12:48:40 PM

Post# of 401949
Company will be stretched to get $40M even if they buy Adderall rights. Elite has a ton of regulatory issues to work through with Sabril and Adderall (Israel approval launch). Doxy has to get worked out with SunGen and hasn’t budged since approval. I wouldn’t expect any material incremental revenue from any of these initiatives this fiscal year. Might be an opportunity with Loxapine to bring in a little more starting around calendar year end, but again little impact to this fiscal year.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News